Premium
Cardiometabolic Profiles and Gene Expression Following Fish Oil Supplementation: Is There a Role for FADS Genotypes?
Author(s) -
Roke Kaitlin,
Zulyniak Michael,
Gerling Christopher,
Whitfield Jamie,
Spriet Lawrence,
Mutch David
Publication year - 2015
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.29.1_supplement.917.5
Subject(s) - eicosapentaenoic acid , fish oil , docosahexaenoic acid , eicosanoid , biology , arachidonic acid , genotype , endocrinology , medicine , polyunsaturated fatty acid , blood lipids , fatty acid , physiology , biochemistry , gene , cholesterol , fish <actinopterygii> , fishery , enzyme
Consumption of omega‐3 fatty acids (FAs) modifies cardiometabolic risk factors in hyperlipidemic and diabetic individuals; however, their effects in young healthy adults are unclear. We examined the impact of fish oil supplements on blood cardiometabolic markers, FA composition, eicosanoid profiles and gene expression. We then examined whether these endpoints varied with an individual's fatty acid desaturase (FADS) genotype. Young male adults (18 – 25 yrs) consumed daily fish oil supplements (up to 3g omega‐3 FAs) for 12 weeks. Significant reductions in blood triglycerides were seen by week 12. Paradoxically, two omega‐6 derived eicosanoids (PGF2α and TXB2) were increased with supplementation. Whole blood gene expression revealed no differences in key genes regulating eicosanoid production, i.e., ALOX5, ALOX12, ALOX15, COX‐2 and iPLA2. FA analysis showed increases in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in serum and red blood cells (RBCs), and decreases in arachidonic acid (AA). Compared to major allele carriers, individuals with FADS minor allele variants experienced greater increases in EPA levels in serum and RBCs during supplementation. There were no genotype differences for DHA or AA levels. Collectively, our results showed that fish oil supplements alter the eicosanoid profile independent of changes in gene expression. Additionally, we demonstrated that changes in FA levels after supplementation are influenced by an individual's FADS genotype. Further investigations regarding the relationship between fish oil supplements, eicosanoid profiles, and FADS genotype are warranted. Grant Funding Source: Supported by NSERC